AstraZeneca Pays $425 Million to Settle Nexium and Prilosec Liability Litigation
03 Oktober 2023 - 8:47AM
Dow Jones News
By Michael Susin
AstraZeneca has agreed to settle product liability litigations
related to Nexium and Prilosec in the U.S. by making a payment of
$425 million, it said.
The Anglo-Swedish pharma giant said Tuesday that it has resolved
the litigations under confidential terms.
The settled claims were pending in the Multidistrict Litigation
District Court of New Jersey, as well as in the Delaware Superior
Court and the New Jersey Superior Court.
The company said a single case remains pending in the U.S.
District Court for the Middle District of Louisiana. Trial is
scheduled for April 15, 2024.
Nexium and Prilosec are used to treat acid-related symptoms.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
October 03, 2023 02:32 ET (06:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
